Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-407.28	-73.74	-14.54
Graham Fair Price	-84.39	0.89	5.73
PEG	21701.55	0.04	< 0.005
Price/Book	-45.74	2.38	4.38
Price/Cash Flow	-91.11	18.29	-205.71
Prices/Earnings	-1598.99	-4.13	-0.24
Price/Sales	-77.03	13.50	58.77
Price/FCF	-91.11	18.29	-205.71
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-84.09	0.14	-0.89
Operating Margin	99.31	-0.41	-59.50
ROA	97.15	-0.02	-0.59
ROE	-4.51	-0.14	96.81
ROIC	-1.15	-0.02	98.58
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.52	-99.56
Dividends QOQ	32.29	-1.00	-96.90
EBIT QOQ	-10.20	0.99	-90.34
EPS QOQ	-12.47	0.97	-92.21
FCF QOQ	0.93	6.35	580.33
Revenue QOQ	-0.72	1.07	48.21
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	752.34	810.36	7.71
Days Sales Outstanding (DSO)	526.38	585.76	11.28
Inventory Turnover	0.12	0.11	-7.16
Debt/Capitalization	0.74	0.77	3.21
Quick Ratio	0.13	0.23	70.01
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	0.57	0.50	-12.67
Cash	0.16	0.12	-24.12
Capex	-0.03	< 0.005	95.95
Free Cash Flow	-0.01	0.06	433.02
Revenue	0.04	0.09	106.28
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.51	0.49	-3.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.42	-41.36	-663.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating